| 摘要 |
This invention relates to novel sulfonyl ureas, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering potassium (ATP) channel blockers.
|
